AI assistant
MICRO-X LIMITED — Call Transcript 2019
Aug 4, 2019
65388_rns_2019-08-04_8f2acd38-d115-44b6-af86-9ccf366a81c7.pdf
Call Transcript
Open in viewerOpens in your device viewer
Micro-X Limited, ABN 21 153 273 735
==> picture [159 x 46] intentionally omitted <==
INVESTOR CALL DETAILS – 7[TH] AUGUST 2019
Investor call at 8.30am AEST, Wednesday 7[th] August 2019 to discuss Results and Business Outlook
Adelaide, Australia, 5[th] August 2019: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in cold cathode x-ray technology for the health and security markets globally, confirms that the Company’s investor conference call will be held at 8.30am AEST on Wednesday 7[th] August 2019 . The Company’s Managing Director, Peter Rowland, will host the call to discuss the Company’s activities and financial results for the Quarter ended 30 June 2019 and the business outlook.
How to Access the Investor Call
To dial into the call directly, please dial in 5 to 10 minutes prior to the call time and enter the Conference ID: 10001532 . Dial in numbers are as follows:
Australian Toll Free: 1800 739 591 New Zealand callers: 0800 452 795 Other callers: +61 2 9007 8048
To pre-register for the call, please follow the link below. A unique pin will be provided for use when dialling into the call, which will bypass the operator and provide immediate access to the event.
https://s1.c-conf.com/diamondpass/microxlimited-10001532-invite.html
Accessing the Call after the event
A recording of the call will be available on the Investor Centre section of the Company’s website for 60 days after the call.
– ENDS –
About Micro-X
Micro-X Limited (the Company ) is an ASX listed hi-tech company developing and commercialising a range of innovative products for the global health and security markets, based on proprietary cold cathode, carbon nanotube emitter technology. The electronic control of emitters with this technology enables X-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. The Company has its core R&D, engineering and production capability at its facility in Adelaide, Australia.
The Company’s first product, the Carestream DRX Revolution Nano , is an ultra-lightweight digital medical x-ray system for the rapidly expanding mobile x-ray market in hospitals and healthcare. The Carestream DRX Revolution Nano holds 510(k) and CE Mark certifications and is sold commercially in a number of global markets by the Company’s exclusive distributor, Carestream Health, Inc.. The Company has a portfolio of innovative products in development, aimed at customer solutions where there is little or no competition. This includes the Mobile Backscatter Imager or MBI which will image Improvised Explosive Devices for airport security, defence and counter-terrorism applications. The MBI is being jointly developed in partnership with Thales, a global supplier of defence and security technology systems, who are providing technical support and $10 million of funding.
CONTACTS
| Micro-X Limited | Investor Enquiries | ||
|---|---|---|---|
| Peter Rowland | David Allen / John Granger | ||
| Managing Director Tel: +61 8 7099 3966 E: [email protected] |
Hawkesbury Partners Tel: +61 2 9103 9494 E: [email protected] [email protected] |
Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042, AUSTRALIA
www.micro-x.com